Compounds
Vitamin D4,97.0%-103.0%
Vitamin D4,511-28-4
(R)-BoroLeu-(+)-Pinanediol-CF3COOH [HOT] [Intermediate]
Cat #
Compound
CAS
(2R)-2-Aminopropanamide hydrochloride
71810-97-4
(2R,3R)-2-amino-3-hydroxy-4-methyl-valeric acid
87421-24-7
(2R,3R)-2-amino-3-hydroxy-succinic acid
16417-36-0
(2R,3R)-3-Me-Glu-OH
97550-61-3
(2R,3S)-diaminosuccinic acid
23220-52-2
(2R,4R)-Diaminoglutaric acid 2Hydrochloride
390362-42-2
(2S)-3-(3-Bromophenyl)-2-(tert-butoxycarbonylamino)propionic acid
82278-73-7
(2S,3R)-2-amino-3-hydroxy-succinic acid
6532-76-9
(2s,3R)-3-Me-Glu-OH
2445-97-8
(2S,3S)-2-Amino-1,3-butanediol
3228-51-1
(2S,3S)-2-amino-3-hydroxy-succinic acid
4294-45-5
(2S,3S)-diaminosuccinic acid
29276-73-1
(2S,4R)-Diaminoglutaric acid 2Hydrochloride
88155-56-0
(2S,4S)-Diaminoglutaric acid 2Hydrochloride
159206-44-7
(3R,2R)-2,3-Diaminobutyric acid 2Hydrochloride
91839-14-6
(3R,2S)-2,3-Diaminobutyric acid 2Hydrochloride
215652-51-0
(3S,2R)-2,3-Diaminobutyric acid 2Hydrochloride
648922-13-8
(3S,2S)-2,3-Diaminobutyric acid 2Hydrochloride
121054-30-6
(5R,2R)-2,5-Diaminoadipic acid dihydrochloride
213686-08-9
(5R,2S)-2,5-Diaminoadipic acid dihydrochloride
213686-09-0
First
Previous
Next
Last
Patent Disclaimer
PD1
Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim.
PD2
Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities.
PD3
the buyer assumes responsibility of all patent considerations in the use of
Lanos' Pharmaceutical Co.,LTD ’s product(s).
PD4
R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.